---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-127477"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:40:33.055483+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# ReShape Lifesciences announces pending merger with Vyome Therapeutics; ticker to change to $HIND

## Summary
- Merger with Vyome Therapeutics Inc. and asset sale to Biorad Medisys or affiliate.
- Ticker symbol to change from RSLS to HIND upon closing.
- Investor presentation furnished as Exhibit 99.1, highlighting clinical-stage immunoinflammation assets.
- No specific deal value or premium disclosed in this filing.
- Approval required from ReShape stockholders; joint proxy statement/prospectus to be filed.

## SEC filing metadata
- accession: 0001104659-24-127477
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465924127477/0001104659-24-127477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465924127477/tm2430703d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-127477
- JSON: https://secwatch.observer/filing/0001104659-24-127477.json
- Plain text: https://secwatch.observer/filing/0001104659-24-127477.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.